QUANTIKINE(TM) ERYTHROPOIETIN HUMAN SERUM CONTROLS

Assay, Erythropoietin

R & D SYSTEMS, INC.

The following data is part of a premarket notification filed by R & D Systems, Inc. with the FDA for Quantikine(tm) Erythropoietin Human Serum Controls.

Pre-market Notification Details

Device IDK931756
510k NumberK931756
Device Name:QUANTIKINE(TM) ERYTHROPOIETIN HUMAN SERUM CONTROLS
ClassificationAssay, Erythropoietin
Applicant R & D SYSTEMS, INC. 614 MCKINLEY PL., N.E. Minneapolis,  MN  55413
ContactKaryn Steere
CorrespondentKaryn Steere
R & D SYSTEMS, INC. 614 MCKINLEY PL., N.E. Minneapolis,  MN  55413
Product CodeGGT  
CFR Regulation Number864.7250 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1993-04-08
Decision Date1994-04-21

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00815762021671 K931756 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.